Remove Bacterium Remove Gene Expression Remove Manufacturing
article thumbnail

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

XTalks

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We COVID-19 Clinical Trials.

article thumbnail

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

Distilleries and breweries used their production facilities to make hand sanitizers while car manufacturers such as GM, Ford and Tesla, and vacuum maker Dyson , pledged to convert their assembly lines to make ventilators. Clinicians also started to learn how to better to manage the disease.